SCHEMBL6936967

SCHEMBL6936967

CCOC(=O)C1CC1CNCC(CCCOc1cccc(CC(N)=O)c1)(c1ccccc1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NR1H3 Q13133 6/20 0.42
CACNA1B Q00975 3/20 0.37
PLA2G2A P14555 3/20 0.37
CYP2D6 P10635 2/20 0.36
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA9 Q16790 2/20 0.36
MAPK1 P28482 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
TSHR P16473 1/20 0.35
RAB9A P51151 1/20 0.35
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6515336 0.74 NR1H3 (0.60) NR1H3PLA2G2ACYP2D6MAPK1L3MBTL1
SCHEMBL7537497 0.69 CA1 (0.43) CA12CA1CA2CA9ALDH1A1
SCHEMBL11209971 0.67 PLA2G4B (0.61) NR1H3CYP2D6KCNH2
SCHEMBL6754441 0.67 NR1H3 (0.53) NR1H3PLA2G2A
SCHEMBL20558774 0.66 L3MBTL1 (0.48) L3MBTL1NPC1ALDH1A1RAB9A
SCHEMBL20558773 0.66 L3MBTL1 (0.48) L3MBTL1NPC1ALDH1A1RAB9A
SCHEMBL14499511 0.66 NPC1 (0.50) CA12CA1CA2CA9NPC1
SCHEMBL4010528 0.66 TP53 (0.51) NR1H3CA1CA2CA9MAPK1
SCHEMBL13357674 0.65 ROCK1 (0.56) NR1H3
SCHEMBL16841695 0.63 CA1 (0.63) CA12CA1CA2CA9L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1318976-A2 SUBSTITUTED AMINOPROPOXYARYL DERIVATIVES USEFUL AS AGONISTS FOR LXR GLAXO GROUP LIMITED (GB) 2003-06-18 EP disclosed
WO-2002024632-A2 SUBSTITUTED AMINOPROPOXYARYL DERIVATIVES USEFUL AS AGONISTS FOR LXR GLAXO GROUP LIMITED (GB) 2002-03-28 WO disclosed